Wednesday, February 01, 2017 7:58:18 AM
Analysts' Ratings History for Idera Pharmaceuticals (NASDAQ:IDRA)
Show:
Date Firm Action Rating Price Target Details
1/31/2017 Wedbush Initiated Coverage Outperform $6.00 View Rating Details
11/29/2016 Cowen and Company Reiterated Rating Outperform View Rating Details
10/7/2016 S&P Equity Research Boost Price Target $1.86 -> $2.10 View Rating Details
3/12/2016 Piper Jaffray Companies Reiterated Rating Buy View Rating Details
6/15/2015 J P Morgan Chase & Co Initiated Coverage Overweight $6.00
IDRA
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM